Research / DT / Fundamental state Inspectable configuration
State dimensions Filing 0001773383-21-000114 General Corporate
Debt relative to revenue 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.debt_to_revenue
147.07% · OPTIONAL · VALID
Capex intensity 44th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.06% · OPTIONAL · VALID
Operating cash generation 33th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
8.08% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
34.27% · CORE · NOT_ENOUGH_HISTORY
Gross margin 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
81.59% · CORE · VALID
Operating margin 44th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
9.39% · CORE · VALID
R&D intensity 67th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.75% · OPTIONAL · VALID
SBC intensity 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.30% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 172.79%
Current 147.07%
Delta -25.71% Capex Intensity Increased
Previous 1.41%
Current 2.06%
Delta 0.65% Cash Generation Decreased
Previous 39.80%
Current 8.08%
Delta -31.71% Growth Decreased
Previous 34.87%
Current 34.27%
Delta -0.61% Margin Increased
Previous 81.49%
Current 81.59%
Delta 0.11% Profitability Decreased
Previous 10.11%
Current 9.39%
Delta -0.73% R And D Intensity Increased
Previous 16.56%
Current 16.75%
Delta 0.19% Sbc Intensity Increased
Previous 9.18%
Current 11.30%
Delta 2.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.